FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Back


2002P-0025
REF 1
Volume 1

Reference List

Reference 1 - Statement of Karen Midthun, M.D., Director, Office of Vaccine Research and Review, CBER, FDA before the Committee on Government Reform, United States House of Representatives, December 10, 2002.

Reference 2 - Ball LK, Ball R, Pratt RD, An assessment of thimerosal use in childhood vaccines, Pediatrics 2001; 1147-1154. Published Material

Reference 3 - Thimerosal in Vaccines. U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Updated March 21, 2005. Available: http://www.fda.gov/cber/vaccine/thimerosal.htm

Reference 4 - Thimerosal-Containing Vaccines and Neurodevelopmental Disorders, Institute of Medicine (IOM), Washington, D.C.: National Academy Press; 2001. Published Material

Reference 5 - Immunization Safety Review: Vaccine and Autism, Institute of Medicine (IOM), (Executive Summary, at 4) (emphasis in original), Washington, D.C.: National Academy Press; 2004. Published Material

Reference 6 - Plotkin, Stanley A., et al, Vaccines, 4th Edition, 2004. Published Material

Reference 7 - Prevention and Control of Influenza: Recommendations and Reports, CDC’s Advisory Committee on Immunization Practices (ACIP), April 25, 2003. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5208a1.htm

Reference 8 Published Material


Top | Back

Page last updated August 19, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management